{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01019",
      "entity_text" : "angiotensin II",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P12821",
      "entity_text" : "ACE",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The apparent superiority of sartans over ACE I may be due to the selective inhibition of angiotensin II receptor 1, responsible of the pro fibrogenic and pro angiogenic activity of angiotensin, while pro apoptotic and anti-tumorigenic activity of receptor 2 is preserved and even enhanced in patients administered sartans unlike ACE I which prevent the binding of angiotensin II to both receptors [XREF_BIBR].",
  "reading_complete" : "2020-08-08T18:32:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T18:19:18Z",
  "trigger" : "prevent",
  "evidence" : [ "ACE I which prevent the binding of angiotensin II" ],
  "pmc_id" : "5095567",
  "score" : 0
}